Correlation Between PAVmed Series and Lucid Diagnostics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PAVmed Series and Lucid Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PAVmed Series and Lucid Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PAVmed Series Z and Lucid Diagnostics, you can compare the effects of market volatilities on PAVmed Series and Lucid Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PAVmed Series with a short position of Lucid Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PAVmed Series and Lucid Diagnostics.

Diversification Opportunities for PAVmed Series and Lucid Diagnostics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between PAVmed and Lucid is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding PAVmed Series Z and Lucid Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lucid Diagnostics and PAVmed Series is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PAVmed Series Z are associated (or correlated) with Lucid Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lucid Diagnostics has no effect on the direction of PAVmed Series i.e., PAVmed Series and Lucid Diagnostics go up and down completely randomly.

Pair Corralation between PAVmed Series and Lucid Diagnostics

Assuming the 90 days horizon PAVmed Series Z is expected to generate 30.35 times more return on investment than Lucid Diagnostics. However, PAVmed Series is 30.35 times more volatile than Lucid Diagnostics. It trades about 0.13 of its potential returns per unit of risk. Lucid Diagnostics is currently generating about 0.0 per unit of risk. If you would invest  28.00  in PAVmed Series Z on August 31, 2024 and sell it today you would lose (26.49) from holding PAVmed Series Z or give up 94.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy70.44%
ValuesDaily Returns

PAVmed Series Z  vs.  Lucid Diagnostics

 Performance 
       Timeline  
PAVmed Series Z 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in PAVmed Series Z are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, PAVmed Series showed solid returns over the last few months and may actually be approaching a breakup point.
Lucid Diagnostics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Lucid Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Lucid Diagnostics exhibited solid returns over the last few months and may actually be approaching a breakup point.

PAVmed Series and Lucid Diagnostics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PAVmed Series and Lucid Diagnostics

The main advantage of trading using opposite PAVmed Series and Lucid Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PAVmed Series position performs unexpectedly, Lucid Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lucid Diagnostics will offset losses from the drop in Lucid Diagnostics' long position.
The idea behind PAVmed Series Z and Lucid Diagnostics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios